G Medical Innovations Holdings (GMVDF) Stock Statistics & Valuation Metrics

G Medical Innovations Holdings has a market cap or net worth of $25.99K. The enterprise value is $14.34.

G Medical Innovations Holdings has 259,918,180 shares outstanding. The number of shares has decreased by -2.65% in one year.

G Medical Innovations Holdings’s return on equity (ROE) is 3.35 and return on invested capital (ROIC) is 892.01%.

The current PE Ratio of G Medical Innovations Holdings is ―. G Medical Innovations Holdings’s PEG ratio is 0.00.

In the last 12 months, G Medical Innovations Holdings had revenue of 4.42M and earned -24.63M in profits. Earnings per share was -34.17.

In the last 12 months, operating cash flow was -26.76M and capital expenditures -2.34M, giving a free cash flow of -29.10M billion.

G Medical Innovations Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

G Medical Innovations Holdings upcoming earnings date is Nov 18, 2022, TBA (Confirmed).

G Medical Innovations Holdings as a current ratio of ―, with Debt / Equity ratio of -28.45%

In the past 12 months, G Medical Innovations Holdings has paid 16.00K in taxes.

G Medical Innovations Holdings EV to EBITDA ratio is -0.48, with an EV/FCF ratio of -0.20.

G Medical Innovations Holdings has $1.51M in cash and marketable securities with $2.18M in debt, giving a net cash position of -$669.00K billion.

Gross margin is 17.74%, with operating margin of ―, and net profit margin of ―.

The average price target for G Medical Innovations Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―